SPG
45
2
ZION
49
9
EXR
42
5
SBUX
29
-2
HIG
48
5
GOOG
77
14
A
43
2
AMAT
33
3
OKE
61
2
TGNA
48
5
VNO
46
6
OMC
37
2
ES
12
3
ADP
57
2
AXP
63
3
KLAC
45
3
F
38
4
VRSN
59
4
HES
49
2
PCG
59
9
SPG
45
2
ZION
49
9
EXR
42
5
SBUX
29
-2
HIG
48
5
GOOG
77
14
A
43
2
AMAT
33
3
OKE
61
2
TGNA
48
5
VNO
46
6
OMC
37
2
ES
12
3
ADP
57
2
AXP
63
3
KLAC
45
3
F
38
4
VRSN
59
4
HES
49
2
PCG
59
9
Financhill
Back

Xeris Biopharma Holdings Vs. Nukkleus Industry Stock Comparison

Buy
74

XERS
Xeris Biopharma Holdings

Last Price:
$3.49
Seasonality Move:
-18.08%
Sell
46

NUKK
Nukkleus

Last Price:
$40.15
Seasonality Move:
-21.57%
Buy
74
Xeris Biopharma Holdings (XERS) is a Buy

Is Xeris Biopharma Holdings a Buy, Sell or Hold?

  • The current Xeris Biopharma Holdings [XERS] share price is $3.49. The Score for XERS is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
  • XERS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
46
Nukkleus (NUKK) is a Sell

Is Nukkleus a Buy, Sell or Hold?

  • The current Nukkleus [NUKK] share price is $40.00. The Score for NUKK is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • NUKK is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

XERS Stock Price Chart

What is Xeris Biopharma Holdings's stock price today?

  • The Xeris Biopharma Holdings share price today is $3.49
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and XERS is experiencing slight buying pressure.

NUKK Stock Price Chart

What is Nukkleus's stock price today?

  • The Nukkleus share price today is $40.00
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NUKK is experiencing slight selling pressure.

XERS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.06 Buy
Relative Strength Index (14 RSI): 55.91 Buy
Chaikin Money Flow: 422045 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.09 - 3.55) Buy
Bollinger Bands (100): (2.64 - 3.32) Buy

NUKK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 8.69 Buy
Relative Strength Index (14 RSI): 77.28 Buy
Chaikin Money Flow: -1366926 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (-7.5 - 22.6) Buy
Bollinger Bands (100): (-4.22 - 11.5) Buy

XERS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.39 Buy
20-day SMA: 3.41 Buy
50-day SMA: 3.24 Buy
200-day SMA: 2.55 Buy
8-day EMA: 3.41 Buy
20-day EMA: 3.38 Buy
50-day EMA: 3.24 Buy
200-day EMA: 2.75 Buy

NUKK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 20.07 Buy
20-day SMA: 9 Buy
50-day SMA: 4.99 Buy
200-day SMA: 4.78 Buy
8-day EMA: 26.51 Buy
20-day EMA: 14.21 Buy
50-day EMA: 7.47 Buy
200-day EMA: 11.77 Buy

Xeris Biopharma Holdings Earnings Growth & XERS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.13 per share, and an increase next year of $0.05 per share.

Nukkleus Earnings Growth & NUKK Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Xeris Biopharma Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nukkleus Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):